Immunic Stock Price on March 31, 2021

IMUX Stock  USD 1.24  0.01  0.81%   
Below is the normalized historical share price chart for Immunic extending back to April 17, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immunic stands at 1.24, as last reported on the 25th of April, with the highest price reaching 1.31 and the lowest price hitting 1.23 during the day.
IPO Date
17th of April 2014
200 Day MA
1.4451
50 Day MA
1.3258
Beta
1.948
 
Yuan Drop
 
Covid
If you're considering investing in Immunic Stock, it is important to understand the factors that can impact its price. Immunic appears to be relatively risky, given 3 months investment horizon. Immunic holds Efficiency (Sharpe) Ratio of 0.0493, which attests that the entity had a 0.0493% return per unit of risk over the last 3 months. We have found thirty technical indicators for Immunic, which you can use to evaluate the volatility of the firm. Please utilize Immunic's Downside Deviation of 4.49, risk adjusted performance of 0.0383, and Market Risk Adjusted Performance of 0.1573 to validate if our risk estimates are consistent with your expectations.
  
At this time, Immunic's Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 81.3 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 27.5 M in 2024. . Price Earnings To Growth Ratio is likely to rise to 0.01 in 2024, whereas Price Earnings Ratio is likely to drop (0.75) in 2024. Immunic Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0493

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsIMUX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.35
  actual daily
38
62% of assets are more volatile

Expected Return

 0.21
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
3
97% of assets perform better
Based on monthly moving average Immunic is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunic by adding it to a well-diversified portfolio.
Price Book
4.4761
Book Value
0.64
Enterprise Value
66.2 M
Enterprise Value Ebitda
(0.85)
Shares Float
49.4 M

Immunic Valuation on March 31, 2021

It is possible to determine the worth of Immunic on a given historical date. On March 31, 2021 Immunic was worth 10.98 at the beginning of the trading date compared to the closed value of 11.05. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunic stock. Still, in general, we apply an absolute valuation method to find Immunic's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunic where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunic's related companies.
 Open High Low Close Volume
04/11/2022
  10.98    11.07    10.66    11.05    88,500  
  11.15    11.46    10.70    10.78    250,400  
Backtest Immunic  |  Immunic History  |  Immunic Valuation Next  
Open Value
10.98
11.05
Closing Value
24.02
Upside

Immunic Trading Date Momentum on March 31, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Immunic Fundamentals Correlations and Trends

By evaluating Immunic's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunic's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunic financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Immunic Stock history

Immunic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunic will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunic stock prices may prove useful in developing a viable investing in Immunic
Last ReportedProjected for Next Year
Common Stock Shares Outstanding44.3 M46.5 M
Net Loss-108.4 M-102.9 M

Immunic Quarterly Net Working Capital

27.8 Million

Immunic Stock Technical Analysis

Immunic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunic technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunic trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Immunic Period Price Range

Low
April 11, 2022
0.07  0.64%
High

 10.98 

     

 11.05 

Immunic April 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Immunic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunic shares will generate the highest return on investment. By undertsting and applying Immunic stock market strength indicators, traders can identify Immunic entry and exit signals to maximize returns

Immunic Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Immunic's price direction in advance. Along with the technical and fundamental analysis of Immunic Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Immunic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunic Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Immunic Stock analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Immunic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunic. If investors know Immunic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.11)
Return On Assets
(0.68)
Return On Equity
(1.31)
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.